Form 8-K

8-K — American Healthcare REIT, Inc.

Accession: 0001193125-26-380473

Filed: 2026-09-02

Period: 2026-09-02

CIK: 0001632970

SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ahr-20260902.htm (Primary)

EX-10.1 (ahr-ex10_1.htm)

EX-10.2 (ahr-ex10_2.htm)

EX-99.1 (ahr-ex99_1.htm)

GRAPHIC (img32265050_0.jpg)

GRAPHIC (img113956633_0.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: ahr-20260902.htm · Sequence: 1

8-K

0001632970false00016329702026-09-022026-09-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 02, 2026

American Healthcare REIT, Inc.

(Exact name of Registrant as Specified in Its Charter)

Maryland

001-41951

47-2887436

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

18191 Von Karman Avenue, Suite 300

Irvine, California

92612

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 949 270-9200

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value per share

AHR

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.

On September 2, 2026, we announced the appointment of Aric Chang as our Chief Financial Officer, effective October 1, 2026, following the September 2, 2026 notification by Brian S. Peay of his decision to retire as Chief Financial Officer, effective September 30, 2026.

Aric Chang, age 47, has served as Chief Financial Officer, Real Estate at Public Storage (NYSE: PSA), an S&P 500 real estate company, since May 2023, where he has led teams spanning real estate and corporate finance, financial planning and analysis, investment underwriting and real estate data analytics. Mr. Chang’s career has spanned public and private markets since 2001. Prior to joining Public Storage in 2023, he held senior finance positions at multiple publicly traded real estate investment trust, or REITs, including Rexford Industrial Realty, Inc., an industrial REIT, where he served as Senior Vice President, Investor Relations and Capital Markets from August 2022 to April 2023, and Rouse Properties, Inc., a mall and retail REIT, where he managed corporate finance and debt restructuring from 2013 to 2015, prior to that company’s acquisition by Brookfield. From 2015 to August 2022, Mr. Chang served as Executive Director, Research & Strategy at J.P. Morgan Asset Management, a real estate investment platform managing over $80 billion of assets across multiple equity and debt strategies. Earlier in his career, he held senior REIT research roles at Green Street Advisors and Oak Hill REIT Management, a real estate long/short hedge fund sponsored by the Robert M. Bass family office. Mr. Chang holds a B.S. in Economics from the Wharton School at the University of Pennsylvania and an M.B.A. from Columbia Business School.

In connection with Mr. Chang’s appointment, following approval by our Board of Directors, or the Board, upon the recommendation of the Compensation Committee of the Board, or the Compensation Committee, we and Mr. Chang entered into an employment letter on September 2, 2026, or the Chang Offer Letter, memorializing the terms of his employment, which includes the following compensation elements: (i) an annual base salary of $500,000; (ii) a target annual bonus opportunity equal to 100% of Mr. Chang’s base salary, pro-rated based on his period of service during 2026; (iii) beginning in 2027, an annual long-term incentive award with a target grant date fair value of $1,000,000, delivered 50% in restricted stock units and 50% in performance-based restricted stock units and (iv) participation in the American Healthcare Opps Holdings, LLC Executive Severance and Change in Control Plan. Additionally, as an inducement for Mr. Chang to join our company, he will also receive a cash payment of $310,000, payable within 30 days following his start date. The description of the Chang Offer Letter is qualified in its entirety by the Chang Offer Letter attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

In order to support the transition of his duties, Mr. Peay will serve as a non-employee consultant from his retirement date through April 15, 2027, or the Consulting Period. Pursuant to the terms of a transition and separation agreement and general release between our company and Mr. Peay, dated September 2, 2026, or the Transition Agreement, as compensation for his services as a consultant and in exchange for a release of claims in favor of our company, Mr. Peay will receive a consulting payment equal to his base salary through the remainder of 2026, payout under our 2026 short-term incentive program equal to 150% of his 2026 base salary, accelerated vesting of 18,159 shares of restricted stock that were granted to Mr. Peay on February 9, 2024 and a payment of $45,000 as reimbursement for the expected health continuation premiums to be incurred by Mr. Peay under COBRA. In addition, Mr. Peay’s outstanding equity awards will continue to vest during the Consulting Period. The description of the Transition Agreement is qualified in its entirety by the Transition Agreement attached as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

Mr. Peay’s decision to retire is not as a result of any disagreement with our company on any matter relating to our operations, policies or practices. There are no arrangements or understandings between Mr. Chang and any other persons pursuant to which he was selected as an officer of our company. There are no family relationships between Mr. Chang and any director or executive officer of our company and there are no transactions involving our company that would be required to report pursuant to Item 404(a) of Regulation S-K.

Item 7.01 Regulation FD Disclosure.

On September 2, 2026, we issued a press release relating to the matters described in Item 5.02 above. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information contained in this Item 7.01, including Exhibit 99.1, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

10.1

Employment Letter, dated as of September 2, 2026, by and between American Healthcare REIT, Inc. and Aric Chang*

10.2

Transition and Separation Agreement and General Release, dated September 2, 2026, by and among, American Healthcare REIT, Inc., American Healthcare Opps Holdings, LLC and Brian S. Peay^

99.1

American Healthcare REIT, Inc. Press Release, September 2, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Certain information in this exhibit has been redacted pursuant to Item 601(a)(6) of Regulation S-K.

^ Certain information in this exhibit has been redacted pursuant to Item 601(a)(5) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

American Healthcare REIT, Inc.

Date:

September 2, 2026

By:

/s/ Jeffrey T. Hanson

Name: Jeffrey T. Hanson

Title: Chief Executive Officer and Chairman of the Board of Directors

EX-10.1

Filename: ahr-ex10_1.htm · Sequence: 2

EX-10.1

Exhibit 10.1

September 2, 2026

Mr. Aric Chang

[***]

Re: Employment Offer Letter

Dear Aric,

We are pleased to extend an offer of employment to you with American Healthcare Opps Holdings LLC (the “Company”). This letter will serve to confirm the full and complete terms of our employment offer.

Your position will be Chief Financial Officer, and you will be hired as a regular, full-time employee of the Company who is exempt from overtime compensation and for whom reasonable work travel will be required. In your role, you will report to Jeff Hanson, Chief Executive Officer, and Gabe Willhite, President and Chief Operating Officer, and will devote your full working time and attention toward the performance of your duties and in the best interests of the Company and its affiliates. Your estimated start date will be no later than October 1, 2026.

Your monthly base salary will be $41,666.66, payable in accordance with the Company’s normal payroll procedures, and corresponding to an annual base salary of $500,000.

In addition to your base salary, you will be eligible to participate in our annual bonus plan (the “Annual Bonus”), with actual payouts based on achievement of the specific performance goals for each fiscal year to be established by the Company (the “Performance Goals”), with a target bonus opportunity equal to 100% of your base salary and pro-rated based on your start date. In addition, your Annual Bonus opportunity will be pro-rated for service breaks taken for any reason, such as any type of leave of absence. The specific amount of your Annual Bonus, if any, shall be determined by the Company based upon an evaluation of corporate and individual performance against the Performance Goals and shall be subject to the terms of the Annual Bonus program and your continued employment through the date such Annual Bonus is paid (which shall be no later than the March 15th following the conclusion of the applicable performance period). No portion of the incentive compensation is earned until the date it is paid.

In the discretion of the Compensation Committee (the “Committee”) of the Board of Directors of American Healthcare REIT, Inc. (“AHR”), you will be eligible to participate in AHR’s long-term incentive program beginning in 2027. Long-term incentive awards will be subject to the terms of AHR’s Second Amended and Restated 2015 Incentive Plan (the “Plan”) and its form of award agreements for similarly-situated employees.

2 | Page

Your target annual equity grants as part of the long-term incentive program is expected to be as follows: (a) on or before March 31, 2027, an award of AHR restricted stock units (“RSUs”) covering a number of shares of AHR’s common stock having a grant date value equal to no less than $500,000 (based upon AHR’s closing stock price on the grant date or, if the grant date is not a trading day, the immediately preceding trading day), with any resulting fraction rounded down to the nearest whole share of common stock, with the RSUs scheduled to vest in three equal annual installments on the first three anniversaries of the grant date; and (b) on or before March 31, 2027, a performance-based award of AHR restricted stock units (“PSUs”) covering a number of shares of AHR common stock having a grant date value equal to no less than $500,000 (based upon AHR’s closing stock price on the grant date or, if the grant date is not a trading day, the immediately preceding trading day), with any resulting fraction rounded down to the nearest whole share of common stock. The performance goals related to the PSUs shall be consistent with the corporate performance goals approved by the Committee for the performance period of January 1, 2027, through December 31, 2029. The RSUs and PSUs will be subject to the terms of the Plan and an award agreement thereunder, including with respect to vesting.

In addition to the compensation above, upon the commencement of your employment, you will be entitled to a cash payment of $310,000 which will be paid no later than 30 days after your start date.

As Chief Financial Officer, you will not accrue vacation time but will instead be permitted to take unlimited vacation, subject to business needs and the approval of the President and Chief Operating Officer. You will also be provided with paid sick leave in accordance with Company policy and applicable state law. You will be eligible for health and other benefits that will be made available through the Company. The benefits provided by the Company are set forth in an Employee Handbook and other materials that will be provided at the commencement of your employment with the Company. In addition, you will be designated as a participant in the Company’s Executive Severance and Change of Control Plan (the “Executive Severance Plan”). By signing this offer letter, you acknowledge that nothing in this letter prohibits the Company from terminating or modifying any of its compensation or benefits programs at any time.

As a Company employee, you will be expected to abide by AHR’s and the Company’s policies and procedures. Such policies may include, without limitation, stock ownership guidelines, clawback policies, insider trading policies and policies regarding hedging or pledging of AHR common stock.

You agree that you will not, without the written permission of the Company, disclose to any person or entity, or use, other than in connection with the Company's business, any confidential information that you develop or otherwise acquire in the course of your employment with the Company. Confidential information includes, but is not limited to: your work product, inventions, client information, trade secrets of the Company, or any other proprietary information related to the conduct of the Company's business, its financial data or plans, or the marketing of its services. You agree that upon termination of your employment with the Company, you will deliver to the Company any and all confidential information about the Company and/or its clients that you possess, and you will also deliver to the Company any and all Company property in your possession. Nothing in this agreement or any other Company policy or agreement is intended to prohibit you (with or without prior notice to the Company) from reporting to or participating in an investigation with a government agency or authority about a possible violation of law, or from making other disclosures protected by applicable whistleblower statutes.

3 | Page

Further, by singing below, you represent and warrant that you are not restricted by any agreement concerning non-competition or other similar restraints that might impair your ability to perform the duties of your role. Further, you agree that you will not provide us with any information, documents or other materials of any kind that constitute confidential or proprietary information that are protected by confidentiality or similar non-disclosure provisions. By signing below, you acknowledge that we have not asked you for, nor will you provide, any such information.

OUR COMPANY ADHERES TO A POLICY OF EMPLOYMENT-AT-WILL WHICH ALLOWS EITHER PARTY TO TERMINATE THE EMPLOYMENT RELATIONSHIP AT ANY TIME FOR ANY REASON, WITH OR WITHOUT CAUSE OR NOTICE.

Please note that our offer is contingent on successful completion of standard hiring processes, including background check, drug screen, completion of form I-9 and signed Conditions of Employment agreement.

Except as provided in this letter, all terms and conditions of your employment are subject to the Company’s policies, as they may be amended from time to time. When you cease to be employed by the Company, you agree that for a period of one year following your date of termination, you will not solicit (either directly or indirectly) for employment any employees or independent contractors of the Company.

If you have any questions, concerning the above details, please feel free to call me. If you accept this position, please sign below and return to my attention within three (3) business days.

Thank you for your interest in our company.

Sincerely,

/s/ Jeffrey T. Hanson

Jeffrey T. Hanson

Chief Executive Officer and Chairman

Agreed and acknowledged by:

/s/ Aric Chang

Aric Chang

Date:

9/2/2026

EX-10.2

Filename: ahr-ex10_2.htm · Sequence: 3

EX-10.2

Exhibit 10.2

TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASE

American Healthcare Opps Holdings, LLC (the “Company”), and Brian S. Peay (“Employee”) hereby enter into this Transition and Separation Agreement and General Release in connection with Employee’s termination of his employment with the Company (this “Agreement”):

Employee’s employment with the Company will terminate effective September 30, 2026 (the “Termination Date”). From the date this Agreement is mutually executed and delivered by Employee and the Company (“Effective Date”), Employee will continue to be paid his normal wages through and including the Termination Date, as well as all accrued and unused vacation time, and unreimbursed business expenses incurred through the Termination Date. Information regarding Employee’s benefits under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) shall be sent to him under separate cover. Effective as of the Termination Date, Employee hereby resigns from all officer, director, manager, trustee and similar positions he holds with the Company, AHR and each of their respective subsidiaries, affiliates and joint ventures, and agrees to execute such further documents as the Company may reasonably request to evidence such resignations.

Employee and Company mutually desire to bring the employment relationship to an amicable conclusion and fully and finally resolve any claims or disputes Employee may have against the Company arising from or related to his employment with and/or separation from the Company. Employee represents that he is signing this Agreement voluntarily and with a full understanding of and in agreement with its terms. By signing this Agreement, the Employee acknowledges that he shall have no entitlements to any amounts payable under the American Healthcare Opps Holdings, LLC Executive Severance and Change in Control Plan (the “Severance Plan”). Company hereby waives any notice period required under the Severance Plan for Employee to resign without Good Reason.

Employee and the Company acknowledge and agree that the Company, in consideration for Employee’s execution and non-revocation of this Agreement (including all releases contained herein), shall provide the following:

Consulting Period. Employee shall be provided with the opportunity to serve as a consultant with the Company beginning on the Termination Date and ending on April 15, 2027 (the “Consulting Period”) during which time he shall remain available to the Company to provide transition assistance and knowledge transfer as the Company may request from time to time, and for which Employee shall receive the amount corresponding to the unpaid portion of Employee’s 2026 Base Salary within thirty (30) days of the Termination

Initial

/s/ BSP

Date. Additional terms regarding the performance of the Consulting Services are set forth in Section 5, below.

2026 STIP Bonus Payout. The Company will pay to Employee an amount equal to 150% of Employee’s 2026 Base Salary (equivalent to $830,812.50) within thirty (30) days of the Employee’s execution and non-revocation of the Supplemental Release attached hereto as Exhibit A, and in accordance with the terms contained therein. Such payment shall be in full satisfaction of any amount otherwise payable or that may become payable to Employee under the Company’s 2026 short-term incentive program.

Vesting of Time-based RSUs and RSAs. Subject to Employee’s continued service during the Consulting Period, continued vesting of the annual time-based restricted stock unit awards (“RSUs”) and/or restricted stock awards (“RSAs”) granted to Employee in 2024, 2025 and 2026 (excluding the IPO Restricted Stock (as defined below)) which are scheduled to vest on or before the expiration of the Consulting Period in accordance with the vesting schedules set forth in the underlying equity award agreements, with such awards to be settled in accordance with the terms of the award agreements based on such continued service or such earlier date as required to comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). For the avoidance of doubt, any portion of the RSUs and RSAs that are scheduled to vest following the conclusion of the Consulting Period shall be forfeited upon the expiration of the Consulting Period.

Accelerated Vesting of Performance-based PSUs. Vesting and settlement in March 2027 of 100% of performance-based restricted stock units (“PSUs”) which would have otherwise vested in March 2027. For the avoidance of doubt, the PSUs described in the preceding sentence consist solely of the PSUs granted to Employee in 2024, and the number of such PSUs that vest shall be determined based on actual performance for the applicable performance period as certified by the Compensation Committee of the Board of Directors of AHR (and not at the target or maximum level), on the same basis and at the same time as for the Company’s continuing executive officers. Employee will not be eligible for vesting of any PSUs which would otherwise vest after March 2027.

Special Accelerated Vesting of Restricted Stock. Employee entered into a Restricted Stock Award Agreement with American Healthcare REIT, Inc. (“AHR”) dated as of February 9, 2024, pursuant to which Employee was granted 148,148 shares of AHR common stock, subject to time-based vesting conditions (the “IPO Restricted Stock”). As of the Termination Date, 50% of the shares of IPO Restricted Stock vested, while the remaining 50% remains

Employee’s Initials

/s/ BSP

unvested (such unvested IPO Restricted Stock, the “Unvested Stock”). Of the Unvested Stock, 37,037 will vest on February 9, 2027, assuming the Consulting Services continue to be provided during the Consulting Period. In consideration for Employee’s execution and non-revocation of this Agreement and the performance of services during the Consulting Period, in addition to the shares that will become vested as of February 9, 2027, pursuant to Section 3.c. above, 18,519 shares of Unvested Stock shall become fully vested within thirty (30) days of the Termination Date (the “Accelerated Vesting”). All other Unvested Stock shall be forfeited as of the Termination Date.

Subsidy Payment. In acknowledgment of the expenses that Employee is expected to incur with respect to continuation coverage under the Company’s medical plans pursuant to COBRA, the Company (or a parent or subsidiary thereof) will pay to Employee, within thirty (30) days of the Termination Date, a lump sum cash payment of $45,000, less applicable taxes and withholdings.

Restricted Trading. From the Effective Date until the Termination Date, Employee shall be permitted to trade AHR common stock during any open trading periods (subject to any lockup, quiet periods, or other trading restrictions set forth in AHR’s insider trading policy); provided, however, such trades shall not exceed $500,000 in total proceeds.

For the avoidance of doubt, Employee acknowledges and agrees that the payments and benefits provided for in this Agreement constitute his sole and exclusive entitlement to any compensation in relation to the cessation of his employment, and, further, that he is relinquishing any claim he may have to any other compensation not specifically set forth in this Agreement, including, without limitation, any claim for any annual bonus, any claim for additional equity, or any claim for severance pay under the Severance Plan.

As a Consultant to the Company during the Consulting Period, you will be responsible for advising the Company in any area of your expertise at the request and direction of the Company’s Chief Executive Officer (the “CEO”) (the “Consulting Services”). You will conduct the Consulting Services remotely or at such locations to be mutually agreed upon and will exercise the highest degree of professionalism in performing the Consulting Services. During the Consulting Period, you are required to comply with all Company policies that apply to the Company’s consultants and independent contractors. The Consulting Period shall automatically terminate on April 15, 2027, or an earlier date agreed to by the parties in writing.

a. Employee understands that, notwithstanding the termination of Employee’s employment, he is obligated to maintain confidential any and all privileged, confidential, and/or proprietary information of the Company, including but not limited to

Employee’s Initials

/s/ BSP

client lists, attorney work product, billing rates, budgets, client documents, or other confidential or proprietary Company or client information to which Employee had access in the performance of his job duties. Employee acknowledges and agrees to abide by the obligations under that letter agreement included as an exhibit to the Severance Plan.

b. Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prohibits Employee (or Employee’s attorney) from confidentially or otherwise communicating or filing a charge or complaint with a governmental or regulatory entity, participating in a governmental or regulatory entity investigation, or giving other disclosures to a governmental or regulatory entity concerning suspected violations of the law, in each case without receiving prior authorization from or having to disclose any such conduct to the Company, or from responding if properly subpoenaed or otherwise required to do so under applicable law. Nothing in this Agreement shall be construed to affect the Equal Employment Opportunity Commission’s (“Commission”), National Labor Relations Board’s, the Occupational Safety and Health Administration’s, and the Securities and Exchange Commission’s, or any federal, state, or local governmental agency or commission’s (“Governmental Agencies”) or any state agency’s independent right and responsibility to enforce the law, nor does this Agreement affect Employee’s right to file a charge or participate in an investigation or proceeding conducted by either the Commission or any such Governmental Agency, although this Agreement does bar any claim that Employee might have to receive monetary damages in connection with any Commission or Governmental Agency proceeding concerning matters covered by this Agreement. This Agreement does not limit Employee’s right to receive an award or bounty for information provided to any Governmental Agencies, including under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank”). Nothing in this Agreement prohibits Employee from testifying in an administrative, legislative or judicial proceeding regarding alleged criminal conduct or sexual harassment, when Employee has been required or requested to attend a proceeding pursuant to court order, subpoena, or written request from an administrative agency or the legislature. Moreover, nothing in this Agreement prevents the disclosure of factual information relating to claims of sexual assault, sexual harassment, harassment or discrimination based on sex, failure to prevent harassment or discrimination based on sex or retaliation against a person for reporting an act of harassment or discrimination based on sex, as those claims are defined under the California Fair Employment and Housing Act, to the extent the claims are filed in a civil or administrative action, and to the extent such disclosures are protected by law. Finally, nothing in this Agreement shall be construed to prohibit Employee from engaging in protected concerted activity under the National Labor Relations Act for the purpose of collective bargaining or other mutual aid or protection, including, without limitation, (i) making disclosures concerning this Agreement in aid of such concerted activities, (ii) filing unfair labor practice charges, (iii) assisting others who are filing such charges, and (iv) cooperating with the investigative process of the National Labor Relations Board or other government agencies.

Employee, for himself or herself and his or her heirs, successors and assigns, does hereby release, acquit and forever discharge the Company, its parent

Employee’s Initials

/s/ BSP

company, AHR, and each of the Company’s and AHR’s former and/or current owners, executives, partners, managers, attorneys, employees, agents, and related affiliates, parents, subsidiaries, or sister companies and their former and/or current owners, partners, executives, managers, attorneys, employees, and/or agents (collectively the “Released Parties”), from any and all claims, actions, charges, complaints, causes of action, rights, demands, debts, damages or accountings of whatever nature, whether known or unknown, which he or she or his or her heirs may have against the Released Parties based on any actions or events which occurred prior to the date he or she executes this Agreement, including but not limited to, those related to, or arising from, Employee’s separation from the Company and/or arising under the Severance Plan. This includes, but is not limited to, a release of all rights arising out of alleged violations of any contracts, express or implied, any covenant of good faith and fair dealing, express or implied, any tort, any public policy or any federal, state or other governmental statute, regulation or ordinance, and any amendments thereto (such as, but not limited to, the Fair Employment and Housing Act, Title VII, the Fair Credit Reporting Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the California Family Rights Act, the Consumer Credit Reporting Agencies Act, the California Labor Code and governing Industrial Welfare Commission Wage Order, and/or all other laws governing persons in the State of California) (hereinafter collectively, “Claim” or “Claims”) from the beginning of time to the date of execution hereof to the fullest extent permitted by state and federal law. Employee further agrees to waive Employee’s right to any monetary or equitable recovery in connection with any federal, state, or local administrative agency’s investigation into any claims arising out of or related to his or her employment with and/or separation from employment with the Company to the fullest extent permitted by law. Execution of this Agreement does not bar any claim that arises hereafter, including (without limitation) a claim for breach of this Agreement, any claim to indemnity under section 2802 of the California Labor Code, or to any claims for indemnification and/or advancement of expenses arising under any indemnification agreement between Employee and the Company or under the bylaws, operating agreement, certificate of incorporation or other similar governing document of the Company or right to coverage for third party claims under the terms of any directors and officers liability insurance policy maintained by the Company, any right to vested benefits Employee may have, if any, as of the date hereof under any applicable “employee benefit plan” (within the meaning of the Employee Retirement Income Security Act of 1974, as amended) maintained by the Company, or any other claim that by law may not be released.

It is further understood and agreed, and Employee acknowledge that Employee has been advised by legal counsel that as a condition of this Agreement, all rights under Section 1542 of the Civil Code of the State of California are expressly waived by Employee. Such Section reads as follows:

A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of

Employee’s Initials

/s/ BSP

executing the Release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.

Notwithstanding the provision of Section 1542, and for the purpose of implementing a full and complete release and discharge of the Released Parties, Employee expressly acknowledges that this Agreement is intended to include and does include in its effect, without limitation, all claims which Employee does not know or suspect to exist in Employee’s favor against the Released Parties, on the date Employee executes this Agreement, and that this Agreement expressly contemplates the extinguishment of all such claims.

Except as required in connection with the performance of consulting services during the Consulting Period or as otherwise approved by the General Counsel of the Company, Employee agrees to return all Company property (keys, badges, access cards, etc.) provided and/or issued to him no later than the Termination Date to the extent Employee has not already done so; provided, however, Employee shall be permitted to retain the laptop computer issued by the Company (subject to removal of any Company confidential information) and the Company issued monitors in possession of Employee. In addition, the Company shall reasonably cooperate with Employee to retain the Company-issued cell phone in possession of Employee and permit Employee to transfer the cell phone number currently assigned to such phone to a cellular carrier designated by Employee.

10.

This Agreement contains all the terms, promises, representations, and understandings made between the parties and supersedes any previous representations, understandings, or agreements between them. Employee understands that he or she is waiving legal rights by signing this Agreement, and that he has been advised to consult, and has consulted, with an attorney and/or other persons to the full extent he wanted to do so before signing this Agreement.

11.

Any dispute regarding the validity or terms of this Agreement shall be resolved by a judicial arbitrator selected in accordance with the procedures of the Judicial Arbitration and Mediation Services, Inc. (“JAMS”) in Orange County, California, as the exclusive remedy for any such dispute. The Agreement to Mutual Mandatory Arbitration of Disputes signed by Employee on May 7, 2024, shall continue to govern any other employment disputes in accordance with its terms.

12.

This Agreement shall be governed by and construed in accordance with the laws of the State of California.

Employee’s Initials

/s/ BSP

13.

The provisions of this Agreement are severable, and if any part of it is found to be unenforceable, the other provisions shall remain fully valid and enforceable. This Agreement shall survive the termination of any arrangements contained herein.

14.

Compliance with Code Section 409A.

This Agreement is intended to comply with Section 409A of the Code (“Section 409A”) or satisfy an exemption thereunder. This Agreement shall be construed, interpreted and administered to the extent possible in a manner that does not result in the imposition on Employee of any additional tax, penalty or interest under Section 409A. Any payments under this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. If any payment or benefit cannot be provided or made at the time specified herein without the imposition on Employee of any additional tax, penalty or interest under Section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such additional tax, penalty or interest will not be imposed. For purposes of Section 409A: (i) any payments to be made under this Agreement upon a termination of employment that constitute “nonqualified deferred compensation” within the meaning of Section 409A shall only be made upon a “separation from service” under Section 409A; (ii) each payment made under this Agreement shall be treated as a separate payment; and (iii) the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. In no event shall Employee, directly or indirectly, designate the calendar year of payment.

All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A, including, where applicable, the requirements that: (i) any reimbursement is for expenses incurred during Employee’s lifetime (or during a shorter period of time specified in this Agreement); (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year; (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred; and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

Notwithstanding any provision in this Agreement to the contrary, if, at the time of Employee’s separation from service with the Company, the Employee is a “specified employee” (as defined in Section 409A) and it is

Employee’s Initials

/s/ BSP

necessary to postpone the commencement of any severance payments otherwise payable pursuant to this Agreement as a result of such separation from service to prevent any accelerated or additional tax under Section 409A, then the Company will postpone the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to Employee) that constitute “nonqualified deferred compensation” under Section 409A until the first payroll date that occurs after the date that is six (6) months following Employee’s separation from service with the Company (as determined under Section 409A). If any payments are postponed pursuant to this Section, then such postponed amounts will be paid in a lump sum, without interest, to Employee on the first payroll date that occurs after the date that is six (6) months following Employee’s separation from service with the Company. If Employee dies during the postponement period prior to the payment of any postponed amount, such amount shall be paid to the personal representative of Employee’s estate within sixty (60) days after the date of Employee’s death.

Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by Employee on account of non-compliance with Section 409A.

15.

Counterparts and Electronic Signature. This Agreement may be executed in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.

[Signature page follows]

Employee’s Initials

/s/ BSP

COMPANY

AMERICAN HEALTHCARE OPPS HOLDINGS, LLC,

a Delaware limited liability company

By:

/s/ Jeffrey T. Hanson

Jeffrey T. Hanson, Authorized Signatory

EMPLOYEE

BRIAN S. PEAY

Signature:

/s/ Brian S. Peay

Name:

Brian S. Peay

Date signed:

9/2/2026

Employee’s Initials

/s/ BSP

Exhibit A

SUPPLEMENTAL RELEASE

Employee’s Initials

_____

EX-99.1

Filename: ahr-ex99_1.htm · Sequence: 4

EX-99.1

Exhibit 99.1

American Healthcare REIT Names Aric Chang Chief Financial Officer

Chang joins from Public Storage, strengthening capital allocation and finance leadership

as AHR scales its operating platform

Chang succeeds Brian Peay, who is retiring following a decade of notable leadership;

appointment effective October 1, 2026

IRVINE, Calif., Sept. 2, 2026 – American Healthcare REIT, Inc. (NYSE: AHR) (the “Company” or “AHR”) today announced that Aric Chang has been appointed Chief Financial Officer, effective October 1, 2026. Chang succeeds Brian Peay, who is retiring after 10 years as Chief Financial Officer. Peay will continue to serve in the role through September 30, 2026.

Chang joins AHR from Public Storage (NYSE: PSA), an S&P 500 real estate company, where he serves as Chief Financial Officer, Real Estate. Across more than two decades in real estate, Chang has built a distinctive combination of public company finance, investment and operating partner experience. His career includes senior roles across New York Stock Exchange-listed REITs, real estate private equity, and REIT research, underscoring the breadth of expertise he brings to AHR.

“AHR is building a company where disciplined capital allocation, leading senior housing operating capabilities, strategic asset management and a modern data and technology platform reinforce one another to drive better resident care outcomes, leading to sustainable growth and long-term value creation,” said Jeff Hanson, Chairman and Chief Executive Officer. “Aric’s combination of public company finance, investment and operating partner experience makes him exceptionally well suited to advance that strategy, and we are delighted to welcome him to AHR.”

Peay joined the Company in 2016 and served as Chief Financial Officer through a period of notable growth and accomplishments, including the Company’s listing on the New York Stock Exchange. “Brian has played an important role in AHR’s growth and evolution, and he leaves the Company in a position of strength, with a solid financial foundation for the opportunities ahead,” Hanson added. “On behalf of the Board of Directors and the entire Company, I want to thank Brian for his service, leadership and partnership to AHR, and we wish him and his family the very best in retirement.”

At Public Storage, Chang leads real estate and corporate finance, financial planning and analysis, investment underwriting and real estate data analytics. During his tenure, he has overseen approximately $16 billion of capital deployment across acquisitions, development, lending and mergers and acquisitions.

“The next phase of AHR’s value creation requires continued exceptional capital allocation, a rigorous capital markets strategy and a finance organization poised to support growth across market cycles,” said Gabe Willhite, President and Chief Operating Officer. “Aric brings all of those capabilities, together with a depth of investment and operating partner experience that is particularly relevant to our business model. His appointment reflects the caliber of leadership we are building across AHR as we position the Company for its next decade of growth and performance.”

Chang’s career has spanned public and private real estate markets since 2001. Before Public Storage, he held senior finance positions at New York Stock Exchange-listed REITs, including Rexford Industrial, where he served as Senior Vice President, Investor Relations and Capital Markets, and Rouse Properties, a mall and retail REIT, where he managed corporate finance and debt restructuring before the company’s acquisition by Brookfield. Earlier in his career, he held senior REIT research roles at Green Street Advisors and Oak Hill REIT Management.

At J.P. Morgan Asset Management, a major investment platform with more than $80 billion of real estate assets under management, Chang served as an Executive Director and a member of the real estate investment committee from 2015 to 2022. He was also the senior strategist for alternative property sectors, with responsibility for operator selection, joint venture relationships and fundraising.

“I am excited to join AHR at a pivotal point in the Company’s evolution,” Chang said. “AHR has built a differentiated healthcare real estate platform with meaningful scale and a strong operating foundation, positioning the Company for compounding value creation. I look forward to working with Jeff, Gabe, the Board and the broader leadership team to further strengthen the Company’s financial and capital allocation capabilities, support disciplined growth and enable AHR to create durable shareholder value.”

Chang holds a bachelor’s degree in economics from The Wharton School of the University of Pennsylvania and an MBA from Columbia Business School.

Chang will lead an experienced finance organization with substantial tenure at AHR, including Kenny Lin, Executive Vice President, Deputy Chief Financial Officer and Chief Accounting Officer; Charlynn H. Diapo, Senior Vice President, Accounting & Finance; and Alan Peterson, Vice President, Investor Relations & Finance.

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.

Forward-Looking Statements

Certain statements contained in this press release, including statements relating to the Company's expectations regarding its performance, growth, long-term value and strategy may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, changing macroeconomic conditions, domestic legal and fiscal policies, geopolitical conditions and other risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 27, 2026, and subsequent periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release.

###

Investor Contact:

Alan Peterson

VP, Investor Relations & Finance

(949) 270-9200

investorrelations@ahcreit.com

Media Contact:

Damon Elder

Spotlight Marketing Communications

(949) 427-1377

damon@spotlightmarcom.com

GRAPHIC

Filename: img32265050_0.jpg · Sequence: 5

Binary file (32191 bytes)

Download img32265050_0.jpg

GRAPHIC

Filename: img113956633_0.jpg · Sequence: 6

Binary file (903168 bytes)

Download img113956633_0.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Document And Entity Information

Sep. 02, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 02, 2026

Entity Registrant Name

American Healthcare REIT, Inc.

Entity Central Index Key

0001632970

Entity Emerging Growth Company

false

Entity File Number

001-41951

Entity Incorporation, State or Country Code

Entity Tax Identification Number

47-2887436

Entity Address, Address Line One

18191 Von Karman Avenue, Suite 300

Entity Address, City or Town

Irvine

Entity Address, State or Province

Entity Address, Postal Zip Code

92612

City Area Code

949

Local Phone Number

270-9200

Entity Information, Former Legal or Registered Name

Not Applicable

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.01 par value per share

Trading Symbol

AHR

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

Former Legal or Registered Name of an entity

+ References

No definition available.

+ Details

Name:

dei_EntityInformationFormerLegalOrRegisteredName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration